About: Jonathan Emberson

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jonathan Emberson Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq)
rdfs:label	Jonathan Emberson (en) Jonathan Emberson (es) Jonathan Emberson (nl) Jonathan Emberson (sl) Jonathan Emberson (ast)
skos:prefLabel	Jonathan Emberson (en) Jonathan Emberson (es) Jonathan Emberson (nl) Jonathan Emberson (sl) Jonathan Emberson (ast)
name	Jonathan Emberson (en) Jonathan Emberson (es) Jonathan Emberson (nl) Jonathan Emberson (sl) Jonathan Emberson (ast)
Scopus author ID	wds:Q43134492-2326FD07-506B-43A7-A9BF-96295BC7FE70
Scopus author ID	6701688192
given name	wds:Q43134492-0A500EE1-44A5-4D12-BCC1-9C4D4EAACFBC
given name	Jonathan
instance of	wds:Q43134492-C393E975-338F-4C4B-A380-ABC8C7D614C3
instance of	Homo sapiens
occupation	wds:Q43134492-45D77B8C-03BD-4CD1-8B09-FB5F914B403E
employer	wds:Q43134492-55BD1668-8F43-4DD9-BF38-6D71AC5DE5A5
sex or gender	wds:Q43134492-995D746F-9C31-4B8B-BF45-AF710FE093A1
VIAF ID	wds:Q43134492-91F80A33-3930-47DD-B16D-D6F633D1E5EB
GND ID	wds:Q43134492-fa90560b-6a79-4afe-8c3f-738134ee6277
family name	wds:Q43134492-E638D37E-3D4F-4EBB-97B3-47B95A25D90A
WorldCat Identities ID (superseded)	wds:Q43134492-8CB8AA58-AC72-4D5D-92ED-24DC79A21B12
VIAF ID	http://viaf.org/viaf/313475947
GND ID	https://d-nb.info/gnd/106648337X
occupation	researcher
employer	University of Oxford
sex or gender	male
VIAF ID	313475947
GND ID	106648337X
family name	Emberson
WorldCat Identities ID (superseded)	viaf-313475947
ORCID iD	wds:Q43134492-27A7DE2E-05F0-410D-AD9B-A251D1CE9770
ORCID iD	https://orcid.org/0000-0001-7792-9422
ORCID iD	0000-0001-7792-9422
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q43134492
is author of	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaborat The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Ensuring trial validity by data quality assurance and diversification of monitoring methods The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart Study Social class differences in coronary heart disease in middle-aged British men: implications for prevention Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional He Text messaging in smoking cessation: the txt2stop trial. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Effects of lowering LDL cholesterol on progression of kidney disease Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials Analyses of cancer data from three ezetimibe trials Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis Randomization is essential for progress in transplant medicine Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12 000 deaths Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? Lifestyle and cardiovascular disease in middle-aged British men: the effect of adjusting for within-person variation Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP) Biochemical measures in a population-based study: effect of fasting duration and time of day. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software